Cargando…

Comment on: Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study

Detalles Bibliográficos
Autores principales:	Suruki, Robert Y, Desai, Rishi J, Davis, Kourtney J, Berlin, Jesse A, Gagne, Joshua J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Published Online Only
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9348766/ https://www.ncbi.nlm.nih.gov/pubmed/35333307 http://dx.doi.org/10.1093/rheumatology/keac157

Ejemplares similares

JAK inhibition for treatment of psoriatic arthritis in Down syndrome
por: Pham, Andrew T., et al.
Publicado: (2021)

Comment on: The sFlt-1 to PlGF ratio in pregnant women with rheumatoid arthritis: impact of disease activity and sulfasalazine use. Reply
por: Smeele, Hieronymus T W, et al.
Publicado: (2021)

Comment on: Comorbidities (excluding lymphoma) in Sjögren’s syndrome. Reply
por: Pego-Reigosa, José M, et al.
Publicado: (2021)

Comment on: The neglected and untreated pains of CRMO and SAPHO syndrome
por: Leerling, Anne T, et al.
Publicado: (2022)

Comment on: Negative associations for fasting blood glucose, cholesterol and triglyceride levels with the development of giant cell arteritis: reply
por: Wadström, Karin, et al.
Publicado: (2021)

Comment on: Epidemiology of biopsy-confirmed giant cell arteritis in southern Sweden—an update on incidence and first prevalence estimate: reply
por: Stamatis, Pavlos, et al.
Publicado: (2021)

Comment on: Plasma Pyruvate Kinase M2 as a marker of vascular inflammation in giant cell arteritis: reply
por: Esen, Idil, et al.
Publicado: (2022)

Risk of major adverse cardiovascular events in patients initiating biologics/apremilast for psoriatic arthritis: a nationwide cohort study
por: Pina Vegas, Laura, et al.
Publicado: (2021)

Comment on: Gudu T, Stober C, Cope AP et al. Baricitinib set to join the Covid-19 therapeutic arsenal?
por: Khan, Sujoy
Publicado: (2021)

Vitamin D-resistant osteomalacia after 10 years of haemodialysis in a patient with rheumatoid arthritis
por: Hatano, Masaki, et al.
Publicado: (2021)

Clinical potential of apremilast in the treatment of psoriatic arthritis
por: Cauli, Alberto, et al.
Publicado: (2014)

Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
por: Mease, Philip J.
Publicado: (2014)

Update on the treatment of psoriasis and psoriatic arthritis – role of apremilast
por: Forchhammer, Stephan, et al.
Publicado: (2015)

Treatment Persistence of Apremilast Among Patients with Psoriatic Arthritis
por: Haddad, Amir, et al.
Publicado: (2023)

Erratum to: Apremilast: A Phosphodiesterase 4 Inhibitor for the Treatment of Psoriatic Arthritis
por: Mease, Philip J.
Publicado: (2015)

Safety and immunogenicity of fifth dose SARS-CoV-2 vaccination in patients with autoimmune disease: a case series
por: Teles, Mayan S, et al.
Publicado: (2022)

Safety of third-dose SARS-CoV-2 vaccination in patients with rheumatic and musculoskeletal disease
por: Connolly, Caoilfhionn M, et al.
Publicado: (2022)

Divergent Metastatic Patterns Between Subtypes of Thyroid Carcinoma Results From the Nationwide Dutch Pathology Registry
por: Hugen, Niek, et al.
Publicado: (2019)

The pharmacokinetic effect of coadministration of apremilast and methotrexate in individuals with rheumatoid arthritis and psoriatic arthritis
por: Liu, Yong, et al.
Publicado: (2014)

First case of pyrin-associated autoinflammation with neutrophilic dermatosis complicated by amyloidosis
por: Kiyota, Masatomo, et al.
Publicado: (2020)

Tofacitinib in patients with refractory Takayasu’s arteritis
por: Li, Jing, et al.
Publicado: (2020)

A case of antisynthetase syndrome with thrombotic thrombocytopenic purpura
por: Goreshnik, Ashley, et al.
Publicado: (2020)

Two Independent Hematological malignancies in a B-Cell Deficient Good Syndrome Patient
por: Koning, Marvyn T, et al.
Publicado: (2020)

A 72-year-old man with life-threatening dyspnoea due to a neck mass of unexpected origin
por: Schubert, Nick M.A., et al.
Publicado: (2021)

Strawberry carina as a presentation of anti-neutrophil cytoplasm antibody–associated vasculitis
por: Chapman, Gavin B, et al.
Publicado: (2021)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

DWI scalp dot sign: superficial temporal artery restricted diffusion in giant cell arteritis
por: Taylor, Eleanor, et al.
Publicado: (2022)

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: comorbidity medications used in rheumatology practice
por: Schreiber, Karen, et al.
Publicado: (2022)

British Society for Rheumatology guideline on prescribing drugs in pregnancy and breastfeeding: immunomodulatory anti-rheumatic drugs and corticosteroids
por: Russell, Mark D, et al.
Publicado: (2022)

Monkeypox in a patient with undifferentiated connective tissue disease
por: Clemente, Tommaso, et al.
Publicado: (2022)

SNP-based heritability estimates of gout and its subtypes determined by genome-wide association studies of clinically defined gout
por: Toyoda, Yu, et al.
Publicado: (2022)

Data Resource Profile: Nationwide registry data for high-throughput epidemiology and machine learning (FinRegistry)
por: Viippola, Essi, et al.
Publicado: (2023)

Cohort Profile: The Danish Occupational Medicine Cohort—a nationwide cohort of patients with work-related disease
por: Dalgaard, Vita Ligaya, et al.
Publicado: (2023)

New developments in the management of psoriasis and psoriatic arthritis: a focus on apremilast
por: Palfreeman, Andrew C, et al.
Publicado: (2013)

Efficacy and Metabolic Effect on Serum Lipids of Apremilast in Psoriatic Arthritis: A Case Report
por: Gualtierotti, Roberta, et al.
Publicado: (2019)

Treatment‐to‐Target With Apremilast in Psoriatic Arthritis: The Probability of Achieving Targets and Comprehensive Control of Disease Manifestations
por: Mease, Philip J., et al.
Publicado: (2020)

Prostate Cancer Incidence under Androgen Deprivation: Nationwide Cohort Study in Trans Women Receiving Hormone Treatment
por: de Nie, Iris, et al.
Publicado: (2020)

Effect of the phosphodiesterase 4 inhibitor apremilast on cardiometabolic outcomes in psoriatic disease—results of the Immune Metabolic Associations in Psoriatic Arthritis study
por: Ferguson, Lyn D, et al.
Publicado: (2021)

Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial
por: Wells, Alvin F, et al.
Publicado: (2018)

Body Composition and Markers of Cardiometabolic Health in Transgender Youth Compared With Cisgender Youth
por: Nokoff, Natalie J, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_c47vmg8p3o8ek7fiisjc4i0ev7